#stayhome Maintain the distance, wash your hands, and follow instructions from the health authorities.
RSS   Newsletter   Contact   Advertise with us

Endologix appoints John Onopchenko as COO

Share on Twitter Share on LinkedIn
Staff Writer | Irvine, Ca., USA | October 20, 2017
EndologixOctober 20, 2017, Irvine, Ca., USA - Endologix, a developer and marketer of innovative treatments for aortic disorders, announced that it has appointed John Onopchenko as the company’s chief operating officer, effective October 30, 2017.
Mr. Onopchenko brings to Endologix almost thirty years of executive leadership experience in medical devices.

Most recently, Mr. Onopchenko was Executive Vice President for Acutus Medical, where he was responsible for program management/product development, quality, marketing, and sales.

Prior to that, he served on the Board of Directors of Volcano Corporation and later became the company’s Executive Vice President / Chief Operating Officer.

Following Volcano’s acquisition by Philips, Mr. Onopchenko was retained as Senior Vice President and Head of Therapy Strategy.

Before joining Volcano, Mr. Onopchenko spent 10 years at Johnson & Johnson, where he led medical device investments with Johnson & Johnson Development Corporation and was responsible for worldwide operations for Advanced Sterilization Products.

Mr. Onopchenko earned his MBA from the University of Chicago and a Bachelor of Science from Ursinus College in Collegeville, Pennsylvania.